Author

E. Chen

Institution: The University of Texas Southwestern Medical Center

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), The University of Texas Southwestern Medical Center

OpenAlex ID: A5027801800

A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension

2008 · S. Oparil, N. Abate, et al. · Current Medical Research and Opinion · 9

195: Changes in weight, body mass index, pancreatic enzyme dose, and vitamin levels after cystic fibrosis transmembrane conductance regulator modulator therapy initiation

2021 · K. Nowak, J. Orofino, et al. · Journal of Cystic Fibrosis · 1

Poster: 521Development of metabolic syndrome in people with cystic fibrosis after prolonged exposure to elexacaftor/tezacaftor/ivacaftor

2026 · E. Chen, S. Brinker, et al. · Journal of Cystic Fibrosis

Works count: 3

Citation count: 10

H-index: 1

I10-index: